A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract
JR Strosberg, A Cheema, LK Kvols - Cancer Control, 2011 - journals.sagepub.com
Background Treatment options for metastatic gastroenteropancreatic neuroendocrine
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
[引用][C] A Review of Systemic and Liver-Directed Therapies for Metastatic Neuroendocrine Tumors of the Gastroenteropancreatic Tract
JR Strosberg, A Cheema, LK Kvols - Cancer Control, 2011 - cir.nii.ac.jp
A Review of Systemic and Liver-Directed Therapies for Metastatic Neuroendocrine Tumors of
the Gastroenteropancreatic Tract | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
the Gastroenteropancreatic Tract | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.
JR Strosberg, A Cheema, LK Kvols - Cancer Control: Journal of the …, 2011 - europepmc.org
Background Treatment options for metastatic gastroenteropancreatic neuroendocrine
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
[PDF][PDF] A Review of Systemic and Liver-Directed Therapies for Metastatic Neuroendocrine Tumors of the Gastroenteropancreatic Tract
JR Strosberg, A Cheema, LK Kvols - Cancer Control, 2011 - Citeseer
Background: Treatment options for metastatic gastroenteropancreatic neuroendocrine
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
[PDF][PDF] A Review of Systemic and Liver-Directed Therapies for Metastatic Neuroendocrine Tumors of the Gastroenteropancreatic Tract
JR Strosberg, A Cheema, LK Kvols - Cancer Control, 2011 - researchgate.net
Background: Treatment options for metastatic gastroenteropancreatic neuroendocrine
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract
JR Strosberg, A Cheema… - Cancer control: journal …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Treatment options for metastatic gastroenteropancreatic neuroendocrine
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
[PDF][PDF] A Review of Systemic and Liver-Directed Therapies for Metastatic Neuroendocrine Tumors of the Gastroenteropancreatic Tract
JR Strosberg, A Cheema, LK Kvols - Cancer Control, 2011 - carcinoid.org
Background: Treatment options for metastatic gastroenteropancreatic neuroendocrine
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …
tumors (NETs) have evolved in recent years. The somatostatin analogs octreotide and …